Thermo Fisher plots $600M manufacturing boost to meet COVID demand—and its work won’t stop there
With COVID-19 top of mind for many contract developers and manufacturers right now, Thermo Fisher Scientific has blueprinted a manufacturing boost to tackle pandemic work in the short-term—and vastly expand capacity in the years to come. Thermo Fisher will upgrade its bioprocessing operations with more than $ 600 million in capital investments, plus at least 1,500 new hires, the company said… Read More »